JP2012522233A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012522233A5 JP2012522233A5 JP2012502618A JP2012502618A JP2012522233A5 JP 2012522233 A5 JP2012522233 A5 JP 2012522233A5 JP 2012502618 A JP2012502618 A JP 2012502618A JP 2012502618 A JP2012502618 A JP 2012502618A JP 2012522233 A5 JP2012522233 A5 JP 2012522233A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- neoepitope
- collagen
- cleavage
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000003776 cleavage reaction Methods 0.000 claims 24
- 230000001900 immune effect Effects 0.000 claims 24
- 102000012422 Collagen Type I Human genes 0.000 claims 10
- 108010022452 Collagen Type I Proteins 0.000 claims 10
- 125000001433 C-terminal amino-acid group Chemical group 0.000 claims 9
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims 9
- 102000004169 proteins and genes Human genes 0.000 claims 9
- 108090000623 proteins and genes Proteins 0.000 claims 9
- 102000001187 Collagen Type III Human genes 0.000 claims 4
- 108010069502 Collagen Type III Proteins 0.000 claims 4
- 102000004266 Collagen Type IV Human genes 0.000 claims 4
- 108010042086 Collagen Type IV Proteins 0.000 claims 4
- 102000012432 Collagen Type V Human genes 0.000 claims 4
- 108010022514 Collagen Type V Proteins 0.000 claims 4
- 102000002734 Collagen Type VI Human genes 0.000 claims 4
- 108010043741 Collagen Type VI Proteins 0.000 claims 4
- 102000016942 Elastin Human genes 0.000 claims 4
- 108010014258 Elastin Proteins 0.000 claims 4
- 108010065472 Vimentin Proteins 0.000 claims 4
- 102000013127 Vimentin Human genes 0.000 claims 4
- 229920002549 elastin Polymers 0.000 claims 4
- 238000003018 immunoassay Methods 0.000 claims 4
- 102000004954 Biglycan Human genes 0.000 claims 3
- 108090001138 Biglycan Proteins 0.000 claims 3
- 102000025380 C-Reactive Protein Human genes 0.000 claims 3
- 108010074051 C-Reactive Protein Proteins 0.000 claims 3
- 102000004237 Decorin Human genes 0.000 claims 3
- 108090000738 Decorin Proteins 0.000 claims 3
- 206010016654 Fibrosis Diseases 0.000 claims 3
- 102100012018 HSPG2 Human genes 0.000 claims 3
- 102000011681 Lumican Human genes 0.000 claims 3
- 108010076371 Lumican Proteins 0.000 claims 3
- 230000004761 fibrosis Effects 0.000 claims 3
- 108010049224 perlecan Proteins 0.000 claims 3
- -1 versican Proteins 0.000 claims 3
- 102000004171 Cathepsin K Human genes 0.000 claims 2
- 108090000625 Cathepsin K Proteins 0.000 claims 2
- 102100007526 NCAN Human genes 0.000 claims 2
- 108010043296 Neurocan Proteins 0.000 claims 2
- 102000035443 Peptidases Human genes 0.000 claims 2
- 108091005771 Peptidases Proteins 0.000 claims 2
- 102000019361 Syndecans Human genes 0.000 claims 2
- 108050006774 Syndecans Proteins 0.000 claims 2
- 108010079292 betaglycan Proteins 0.000 claims 2
- 235000019833 protease Nutrition 0.000 claims 2
- 210000001124 Body Fluids Anatomy 0.000 claims 1
- 102100015724 CRP Human genes 0.000 claims 1
- 102000017177 Fibromodulin Human genes 0.000 claims 1
- 108010013996 Fibromodulin Proteins 0.000 claims 1
- 102000004142 Trypsin Human genes 0.000 claims 1
- 108090000631 Trypsin Proteins 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 238000011002 quantification Methods 0.000 claims 1
- 229960001322 trypsin Drugs 0.000 claims 1
- 239000012588 trypsin Substances 0.000 claims 1
Claims (23)
- 線維症の判定または定量化の方法であって、患者の生体液試料中に天然に存在するネオエピトープ含有タンパク質断片を測定する免疫検定法を実施すること、および正常レベルを上回る、前記患者における前記測定の上昇を線維症の存在または程度と関連付けることを含み、前記免疫検定法が、
前記試料中に天然に存在するタンパク質断片を、プロテイナーゼによるタンパク質の切断によって形成されるネオエピトープと反応性の免疫学的結合パートナと接触させること、および前記ネオエピトープを含むタンパク質断片を測定するために前記免疫学的結合パートナへのペプチド断片の結合の程度を測定することを含む方法によって実施され、前記タンパク質が、III型コラーゲン、I型コラーゲン、IV型コラーゲン、V型コラーゲンもしくはVI型コラーゲン、エラスチン、ビグリカン、デコリン、ルミカン、バーシカン、パールカン、ニューロカン、ブレビカン、フィブロモジュリン、セルグリシン、シンデカン、βグリカン、ビメンチンまたはC反応性タンパク質であり、但し、該ネオエピトープがI型コラーゲンの切断によって形成される場合、該切断は、I型コラーゲンがカテプシンKによって切断される部位ではないことを条件とする、線維症の判定または定量化の方法。 - 前記免疫学的結合パートナが、N末端配列KNGETG…を有するIII型コラーゲン
の断片に特異的に結合する、請求項1に記載の方法。 - 前記免疫学的結合パートナが、N末端配列KAFVFP…(配列番号1167)を有す
るCRPの断片に特異的に結合する、請求項1に記載の方法。 - 前記ネオエピトープがI型コラーゲンの切断によって形成される場合、該切断は、I型
コラーゲンがトリプシンによって切断される部位ではないことをさらなる条件とする、請
求項1に記載の方法。 - 体液試料中に天然に存在するネオエピトープ含有タンパク質断片を測定する免疫検定の
方法であって、前記免疫検定法が、前記試料中に天然に存在するタンパク質断片を、プロ
テイナーゼによるタンパク質の切断によって形成されるネオエピトープに対して反応性で
ある免疫学的結合パートナと接触させるステップと、前記ネオエピトープを含むタンパク
質断片を測定するために前記免疫学的結合パートナへのペプチド断片の結合の程度を測定
するステップとを含む方法によって実施され、ここで、前記タンパク質が、ニューロカン
、ブレビカン、フィブロモジュリン、セルグリシン、シンデカン、βグリカン、エラスチ
ン、I型コラーゲン、IV型コラーゲン、V型コラーゲンもしくはVI型コラーゲン、C
RPまたはビメンチンであり、但し、該ネオエピトープがI型コラーゲンの切断によって
形成される場合、該切断は、I型コラーゲンがカテプシンKによって切断される部位では
ないことを条件とする、免疫検定の方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21146709P | 2009-03-30 | 2009-03-30 | |
US61/211,467 | 2009-03-30 | ||
US28908109P | 2009-12-22 | 2009-12-22 | |
US61/289,081 | 2009-12-22 | ||
PCT/EP2010/054096 WO2010115749A2 (en) | 2009-03-30 | 2010-03-29 | Fibrosis biomarker assay |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015010255A Division JP6095702B2 (ja) | 2009-03-30 | 2015-01-22 | 線維症バイオマーカアッセイ |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2012522233A JP2012522233A (ja) | 2012-09-20 |
JP2012522233A5 true JP2012522233A5 (ja) | 2013-05-16 |
JP5978128B2 JP5978128B2 (ja) | 2016-08-24 |
Family
ID=42199024
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012502618A Expired - Fee Related JP5978128B2 (ja) | 2009-03-30 | 2010-03-29 | 線維症バイオマーカアッセイ |
JP2015010255A Active JP6095702B2 (ja) | 2009-03-30 | 2015-01-22 | 線維症バイオマーカアッセイ |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015010255A Active JP6095702B2 (ja) | 2009-03-30 | 2015-01-22 | 線維症バイオマーカアッセイ |
Country Status (8)
Country | Link |
---|---|
US (3) | US9206464B2 (ja) |
EP (4) | EP2770327B1 (ja) |
JP (2) | JP5978128B2 (ja) |
KR (1) | KR101700463B1 (ja) |
CN (1) | CN103238071B (ja) |
DK (3) | DK2770327T3 (ja) |
ES (2) | ES2635494T3 (ja) |
WO (1) | WO2010115749A2 (ja) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100143949A1 (en) * | 2006-10-31 | 2010-06-10 | George Mason Intellectual Properties, Inc. | Biomarkers for colorectal cancer |
US9404932B2 (en) * | 2007-11-05 | 2016-08-02 | Nordic Bioscience A/S | Pathology biomarker assay |
EP2538221A3 (en) * | 2007-11-05 | 2013-04-24 | Nordic Bioscience A/S | Biochemical markers for CVD risk assessment |
EP2770327B1 (en) | 2009-03-30 | 2017-06-14 | Nordic Bioscience A/S | Fibrosis biomarker assay |
EP2694653A2 (en) | 2011-04-05 | 2014-02-12 | Academisch Ziekenhuis Leiden h.o.d.n. LUMC | Compounds and methods for altering activin receptor-like kinase signalling |
GB201107922D0 (en) * | 2011-05-12 | 2011-06-22 | Nordic Bioscience As | Biochemical markers for CVD risk assessment |
KR101968779B1 (ko) | 2011-05-27 | 2019-04-12 | 노르딕 바이오사이언스 에이/에스 | 진단용 펩티드의 검출 |
US20140170741A1 (en) * | 2011-06-29 | 2014-06-19 | Inner Mongolia Furui Medical Science Co., Ltd | Hepatic fibrosis detection apparatus and system |
GB201111361D0 (en) * | 2011-07-04 | 2011-08-17 | Nordic Bioscience As | Biochemical markers for neurodegenerative conditions |
GB201111788D0 (en) * | 2011-07-11 | 2011-08-24 | Nordic Bioscience As | In vitro assessment of cardiovascular events by assay for neo-epitopes |
JP5953035B2 (ja) * | 2011-11-28 | 2016-07-13 | 学校法人慶應義塾 | 病理診断支援装置、病理診断支援方法、及び病理診断支援プログラム |
US20150160201A1 (en) * | 2012-04-19 | 2015-06-11 | The Regents Of The University Of California | Compositions and Methods for Detecting Unstable Arteriosclerotic Plaques |
GB201306792D0 (en) * | 2013-04-15 | 2013-05-29 | Nordic Bioscience As | PIIINP Neo-epitope assay |
GB201307387D0 (en) | 2013-04-24 | 2013-06-05 | Nordic Bioscience As | Collegen type VI alpha-1 assay |
GB201400472D0 (en) * | 2014-01-13 | 2014-02-26 | Nordic Bioscience As | Biochemical Markers for pulmonary and other diseases |
GB201505654D0 (en) * | 2015-04-01 | 2015-05-13 | Nordic Bioscience As | Immunoassay for collagen type VI sequence |
US20170165294A1 (en) * | 2015-12-11 | 2017-06-15 | Geno Llc | Method and apparatus for administering gases including nitric oxide to address fibrosis |
CA3008621A1 (en) | 2015-12-15 | 2017-06-22 | Dyax Corp. | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk |
GB201601571D0 (en) * | 2016-01-28 | 2016-03-16 | Nordic Bioscience As | Collagen type Vll alpha 1 assay |
WO2017134172A1 (en) * | 2016-02-03 | 2017-08-10 | Nordic Bioscience A/S | Combined biomarker measurement of fibrosis |
CN105738632B (zh) * | 2016-02-24 | 2017-06-23 | 浙江理工大学 | 一种区分羊皮种类的检测方法 |
WO2017160788A2 (en) * | 2016-03-14 | 2017-09-21 | RGENE, Inc. | HYPER-THERMOSTABLE LYSINE-MUTANT ssDNA/RNA LIGASES |
CN115236166A (zh) * | 2016-05-29 | 2022-10-25 | 深圳市绘云生物科技有限公司 | 肝病相关生物标志物和其使用方法 |
ES2902226T3 (es) * | 2017-07-19 | 2022-03-25 | Bio Rad Europe Gmbh | Combinaciones de biomarcadores para evaluar la esteatohepatitis no alcohólica y/o el estatus de la fibrosis hepática |
GB201717301D0 (en) * | 2017-10-20 | 2017-12-06 | Nordic Bioscience As | Type xvi collagen assay |
US20190351031A1 (en) | 2018-05-16 | 2019-11-21 | Halozyme, Inc. | Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20 |
US11028425B2 (en) | 2018-06-08 | 2021-06-08 | Glympse Bio, Inc. | Diagnosis and monitoring of liver disease |
US11732009B2 (en) | 2018-06-08 | 2023-08-22 | Glympse Bio, Inc. | Activity sensor with tunable analyte |
JP2022523120A (ja) * | 2019-02-01 | 2022-04-21 | グリンプス バイオ, インコーポレイテッド | 活性センサーの身体的処理 |
WO2020210440A1 (en) * | 2019-04-12 | 2020-10-15 | Geltor, Inc. | Recombinant elastin and production thereof |
WO2021026337A1 (en) * | 2019-08-07 | 2021-02-11 | Icahn School Of Medicine At Mount Sinai | Method of treating keloids |
GB2610313A (en) | 2020-01-24 | 2023-03-01 | Geltor Inc | Animal-free dietary collagen |
IL274696A (en) * | 2020-05-14 | 2021-12-01 | Yeda Res & Dev | Designed transmembrane polypeptides and their use in cellular immunotherapy |
CN111705123A (zh) * | 2020-06-19 | 2020-09-25 | 上海市第六人民医院 | 一种衰老过程中心肌纤维化的生物标志物及其检测方法和应用 |
JP2023535022A (ja) * | 2020-07-21 | 2023-08-15 | アムニクス ファーマシューティカルズ, インコーポレイテッド | 活性化可能な治療剤に関する組成物および方法 |
CN115322251A (zh) * | 2021-03-23 | 2022-11-11 | 中国科学院理化技术研究所 | 一种促进成骨细胞矿化的牛骨胶原肽及其应用 |
WO2023148165A1 (en) * | 2022-02-01 | 2023-08-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for diagnosing collagen degradatation associated disease |
CN117343132B (zh) * | 2023-09-25 | 2024-03-12 | 山东省农业科学院 | 一种三文鱼鱼皮来源的ace抑制肽及制备方法 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4628027A (en) | 1982-05-19 | 1986-12-09 | Molecular Engineering Associates, Ltd. | Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins |
GB2208865B (en) * | 1987-08-19 | 1991-12-11 | Farmos Group Ltd | Purified propeptide of procollagen type iii, antibody to the propeptide and assay method using the antibody. |
US5962639A (en) * | 1987-11-06 | 1999-10-05 | Washington Research Foundation | Synthetic peptides corresponding to telopeptide sequences of cross-linked type I collagen metabolites |
US6124107A (en) * | 1988-06-10 | 2000-09-26 | Merck & Co., Inc. | Assay for marker of human polymorphonuclear leukocyte elastase activity |
WO1991000872A1 (en) * | 1989-06-27 | 1991-01-24 | Rush-Presbyterian-St. Luke's Medical Centre | Monoclonal antibodies to c-reactive protein |
US5387504A (en) | 1992-09-30 | 1995-02-07 | Merck & Co., Inc. | Monospecific antibodies and assay system for detecting stromelysin cleavage products |
US6703219B1 (en) * | 1993-02-26 | 2004-03-09 | Immtech International Inc. | Mutant protein and methods and materials for making and using it |
US6110689A (en) * | 1994-01-21 | 2000-08-29 | Osteometer A/S | Method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen |
JPH08100000A (ja) * | 1994-09-30 | 1996-04-16 | Morinaga & Co Ltd | ヒトiv型コラーゲンに対する抗体及びその利用 |
DE59505585D1 (de) * | 1994-12-23 | 1999-05-12 | Roche Diagnostics Gmbh | Antigene und Antikörper zum Nachweis von Kollagen I |
US6060255A (en) | 1997-10-03 | 2000-05-09 | Tosoh Corporation | Type IV collagen high molecular form and production and diagnostic use thereof |
EP0913692A1 (en) * | 1997-10-31 | 1999-05-06 | Bayer Ag | An immunoassay for procollagen-III-C-terminal propeptide |
WO1999061477A2 (en) | 1998-05-28 | 1999-12-02 | Bayer Aktiengesellschaft | Monoclonal antibody and assay for detecting piiinp |
US6916903B2 (en) * | 1998-06-19 | 2005-07-12 | Washington Research Foundation | Collagen type III synthetic peptides for collagen resorption assays |
JP2002065283A (ja) | 2000-06-12 | 2002-03-05 | Wako Pure Chem Ind Ltd | ハイブリッド酵素およびその用途 |
DE60026337T2 (de) | 2000-08-21 | 2007-01-11 | Assistance Publique, Hopitaux De Paris | Verfahren zur diagnose von leberkrankheit unter verwendung von biochemischen merkmalen |
AU2002251366A1 (en) | 2001-05-02 | 2002-11-11 | Oxford Glycosciences (Uk) Ltd | Proteins, genes and their use for diagnosis and treatment of breast cancer |
US7390885B2 (en) * | 2001-11-26 | 2008-06-24 | Cell Matrix, Inc. | Humanized collagen antibodies and related methods |
CN101906106A (zh) * | 2003-09-18 | 2010-12-08 | 康福玛医药公司 | 作为hsp90-抑制剂的新的杂环化合物 |
US20050255491A1 (en) | 2003-11-13 | 2005-11-17 | Lee Frank D | Small molecule and peptide arrays and uses thereof |
WO2005124341A2 (en) | 2004-06-09 | 2005-12-29 | Anderson Forschung Group Llc | Stable isotope labeled polypeptide standards for protein quantitation |
AR054186A1 (es) * | 2005-02-25 | 2007-06-06 | Serenex Inc | Derivados de tetrahidroindazolona y tetrahidroindolona |
EP1948686A4 (en) | 2005-10-26 | 2009-06-10 | Stc Unm | C-REACTIVE PROTEIN AND ITS USE FOR THE TREATMENT OF SYSTEMIC LUPUSERYTHEMATODES AND RELATED SUFFERINGS |
US7972802B2 (en) * | 2005-10-31 | 2011-07-05 | University Of Washington | Lipoprotein-associated markers for cardiovascular disease |
EP2538221A3 (en) | 2007-11-05 | 2013-04-24 | Nordic Bioscience A/S | Biochemical markers for CVD risk assessment |
US9404932B2 (en) * | 2007-11-05 | 2016-08-02 | Nordic Bioscience A/S | Pathology biomarker assay |
US20100023377A1 (en) * | 2008-07-23 | 2010-01-28 | Hr Solutions, Inc. | Systems and methods for managing human resource activities |
EP2770327B1 (en) | 2009-03-30 | 2017-06-14 | Nordic Bioscience A/S | Fibrosis biomarker assay |
KR101968779B1 (ko) * | 2011-05-27 | 2019-04-12 | 노르딕 바이오사이언스 에이/에스 | 진단용 펩티드의 검출 |
GB201111788D0 (en) * | 2011-07-11 | 2011-08-24 | Nordic Bioscience As | In vitro assessment of cardiovascular events by assay for neo-epitopes |
-
2010
- 2010-03-29 EP EP14169636.9A patent/EP2770327B1/en active Active
- 2010-03-29 EP EP16205956.2A patent/EP3173792B1/en active Active
- 2010-03-29 ES ES14169636.9T patent/ES2635494T3/es active Active
- 2010-03-29 WO PCT/EP2010/054096 patent/WO2010115749A2/en active Application Filing
- 2010-03-29 DK DK14169636.9T patent/DK2770327T3/en active
- 2010-03-29 JP JP2012502618A patent/JP5978128B2/ja not_active Expired - Fee Related
- 2010-03-29 EP EP10715752.1A patent/EP2414844B1/en active Active
- 2010-03-29 DK DK16205956.2T patent/DK3173792T3/da active
- 2010-03-29 DK DK10715752T patent/DK2414844T3/en active
- 2010-03-29 ES ES10715752.1T patent/ES2529101T3/es active Active
- 2010-03-29 EP EP19174151.1A patent/EP3578664A1/en active Pending
- 2010-03-29 KR KR1020117025776A patent/KR101700463B1/ko active IP Right Grant
- 2010-03-29 CN CN201080014281.6A patent/CN103238071B/zh active Active
- 2010-03-30 US US12/749,652 patent/US9206464B2/en active Active
-
2015
- 2015-01-22 JP JP2015010255A patent/JP6095702B2/ja active Active
- 2015-12-07 US US14/960,713 patent/US9606130B2/en active Active
-
2017
- 2017-03-01 US US15/446,070 patent/US9880177B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2012522233A5 (ja) | ||
WO2010115749A3 (en) | Fibrosis biomarker assay | |
NZ600828A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
WO2009059972A3 (en) | Biochemical markers for cvd risk assessment | |
RU2009141523A (ru) | Биомаркеры для рассеянного склероза | |
MXPA05010827A (es) | Determinacion de un peptido parcial de la region mid de la proadrenomedulina en fluidos biologicos para propositos de diagnostico, e inmunoensayos para la conduccion de una identificacion de este tipo. | |
CN104034882B (zh) | 用于测定样本中的待测定成分的方法和试剂盒 | |
NZ619883A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
NZ592552A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1099807A1 (en) | Method for detecting the formation of endothelins for medical diagnosis, and antibodies and kits for carrying out one such method | |
MX337991B (es) | Metodo para detectar cancer. | |
WO2007127977A3 (en) | Methods of evaluating peptide mixtures | |
EP3590959A3 (en) | Pathology biomarker assay | |
BRPI0812875A2 (pt) | " método pra identificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, anticorpo específico para proteína ligante de heparina, método pra reduzir o risco de um indivíduo desenvolver sépsis severa, e, kit de teste ". | |
JP2005505757A5 (ja) | ||
NZ598035A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
DE60129239D1 (de) | Kit und verfahren zur bestimmung von protein esm-1 | |
JP4669929B2 (ja) | 試料の前処理方法及びこれを利用する免疫学的測定方法 | |
JP2020521460A5 (ja) | ||
ATE360034T1 (de) | Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft | |
WO2020067471A1 (ja) | 肝型脂肪酸結合タンパク質を定量する方法、その定量用キット、腎疾患の検査方法、その検査キット及びコンパニオン診断薬 | |
DE602005010548D1 (de) | Verbessertes verfahren zur diagnose des akuten koronarsyndroms | |
Nielsen et al. | Biomarkers of extracellular matrix remodeling in liver diseases | |
EP4162275A1 (en) | Soluble trem-1 as a marker of severity or complications for a subject suffering from a coronavirus infection | |
Cartwright et al. | Conventional immunoassays underestimate anti-GST antibody titre |